Doug Hampton

Les résultats positifs de premier ordre de l’essai de phase 2 montrent que le candidat-vaccin combiné COVID-Influenza de Novavax, le candidat-vaccin autonome contre la grippe et les candidats-vaccins à forte dose contre la COVID-19 présentent de solides réponses immunitaires USA – Français India – English USA – Deutsch USA – English Brazil – Português Latin America – español USA – español

by

Cet essai de phase 2 évalue trois candidats-vaccins : Candidat-vaccin combiné COVID-Influenza, candidat-vaccin autonome contre la grippe et candidat-vaccin à forte dose contre la COVID-19 Les réponses immunitaires initiales de premier ordre des trois candidats-vaccins étaient robustes par rapport aux comparateurs autorisés Pour le candidat-vaccin antigrippal autonome, les réponses de l’IH étaient de 31 à 56 % … Read more

Veeva s’associe à Sanofi pour transformer son système de qualité

by

Une entreprise pharmaceutique de premier plan pour rationaliser les processus de qualité dans l’ensemble de l’entreprise BARCELONE, Espagne, 11 mai 2023 /PRNewswire/ — Veeva Systems (NYSE: VEEV) a annoncé aujourd’hui que Sanofi mettait en œuvre Veeva Vault QMS et Veeva Vault QualityDocs pour moderniser la gestion de la qualité dans l’ensemble de l’entreprise, y compris dans le domaine de la santé grand public … Read more

Pharming Group reports financial results for the first quarter of 2023

by

FDA approval and commercial launch of Joenja® (leniolisib) in the U.S. Joenja® launch off to strong start with 23 U.S. patients on paid therapy Revenues decreased by 9% to US$42.5 million, compared to the first quarter of 2022, primarily due to temporary reimbursement disruptions for some patients on government insurance programs. This issue, affecting all … Read more

UCB and Ariceum Therapeutics sign a Strategic Research Collaboration to Discover New Modalities for the Treatment of Immune-related Diseases and Cancer

by

UCB’s expertise in macrocyclic peptide discovery, using its proprietary mRNA-display platform, ExtremeDiversity™, will aid Ariceum’s discovery of treatments for solid tumors Ariceum’s expertise in radiopharmaceuticals and labelling technology will aid UCB’s discovery of treatments for immune-related diseases Potential to expand Ariceum’s pipeline with three new programs at discovery stage BERLIN and BRUSSELS, May 11, 2023 … Read more

Antidepressants, really effective against chronic pain?

by

With one exception, a large review concludes that there is little evidence that antidepressants are effective in this type of prescription. A work published in the Cochrane collaborative database concludes that “Duloxetine is the only antidepressant whose (interest) is indisputable against chronic pain”. The aim was to assess the potential benefits of 25 antidepressants in … Read more

Niklas Prager appointed new CEO of SmartCella

by

STOCKHOLM, May 11, 2023 /PRNewswire/ — SmartCella Holding AB today announces that Niklas Prager has been appointed as the new CEO. SmartCella is an innovative biotech and medtech company that combines targeted delivery of medical substances to organs and tumors through a unique device, and the development of future stemcell and RNA-based treatments and methods … Read more

BioInnovation Institute appointed by the Danish government to run international deep tech start-up accelerator to unlock the potential in quantum science

by

COPENHAGEN, Denmark, May 11, 2023 /PRNewswire/ — BioInnovation Institute (BII), an international non-profit foundation incubating and accelerating world-class life science research, announces the launch of a new deep tech accelerator start-up program, the Deep Tech Lab – Quantum, to propel emergent and disruptive quantum science and biotechnology solutions toward the marketplace. Deep tech and quantum … Read more

Alameda Health System Publishes the AHS COVID-19 Memory Archive

by

The archive features short oral history interviews with the health care workers who were on the frontline of COVID-19 in Alameda County, California. OAKLAND, Calif., May 11, 2023 /PRNewswire/ — Alameda Health System (AHS) has published an AHS COVID-19 Memory Archive to commemorate the end of the COVID-19 state of emergency on May 11, 2023. Earlier in … Read more

Nippon Express Italia Obtains IATA CEIV Pharma Certification for Its Facility near Milan Malpensa Airport

by

TOKYO, May 11, 2023 /PRNewswire/ — Nippon Express Italia S.p.A. (hereinafter “NX Italia”), a group company of NIPPON EXPRESS HOLDINGS, INC., has acquired IATA CEIV Pharma certification*, a quality certificate for pharmaceutical transport established by the International Air Transport Association (IATA), for its warehouse facility in Lainate, near Milan Malpensa Airport, effective April 3 of this year. Logo: https://kyodonewsprwire.jp/img/202305095498-O1-I17xe4r6 Photos … Read more